INTELLIA THERAPEUTICS, INC. Deferred Revenue
INTELLIA THERAPEUTICS, INC. (NTLA) had Deferred Revenue of $15.68 million as of 2018-06-30, per its 10-Q filed 2018-08-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-08-01
- 2018-06-30: Deferred Revenue, Current $15.68M.
- 2018-03-31: Deferred Revenue, Current $17.06M.
- 2017-12-31: Deferred Revenue, Current $21.19M.
- 2017-09-30: Deferred Revenue, Current $17.65M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-06-30 | $15.68M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $17.06M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $21.19M 10-Q · filed 2018-08-01 |
| 2017-09-30 | $17.65M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $18.79M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $19.92M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $20.18M 10-K · filed 2018-03-14 |
| 2016-09-30 | $17.17M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $16.29M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $6.78M 10-Q · filed 2016-06-03 |
| 2015-12-31 | $6.55M 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |